STAT3 pathway in cancers: Past, present, and future

HQ Wang, QW Man, FY Huo, X Gao, H Lin, SR Li… - MedComm, 2022 - Wiley Online Library
Signal transducer and activator of transcription 3 (STAT3), a member of the STAT family,
discovered in the cytoplasm of almost all types of mammalian cells, plays a significant role in …

Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we?

JD Beebe, JY Liu, JT Zhang - Pharmacology & therapeutics, 2018 - Elsevier
Signal transducer and activator of transcription 3 (STAT3) controls many biological
processes including differentiation, survival, proliferation, and angiogenesis. In normal …

[HTML][HTML] Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery

Y Hu, Z Dong, K Liu - Journal of Experimental & Clinical Cancer Research, 2024 - Springer
Signal transducer and activator of transcription 3 (STAT3) is a transcriptional factor involved
in almost all cancer hallmark features including tumor proliferation, metastasis …

Repurposing of drugs as STAT3 inhibitors for cancer therapy

PS Thilakasiri, RS Dmello, TL Nero, MW Parker… - Seminars in cancer …, 2021 - Elsevier
Drug repurposing is a valuable approach in delivering new cancer therapeutics rapidly into
the clinic. Existing safety and patient tolerability data for drugs already in clinical use …

Revisiting signal transducer and activator of transcription 3 (STAT3) as an anticancer target and its inhibitor discovery: Where are we and where should we go?

Q Huang, Y Zhong, H Dong, Q Zheng, S Shi… - European Journal of …, 2020 - Elsevier
As a transcription factor, STAT3 protein transduces extracellular signals to the nucleus and
then activates transcription of target genes. STAT3 has been well validated as an attractive …

[HTML][HTML] Novel activators and small-molecule inhibitors of STAT3 in cancer

L Yang, S Lin, L Xu, J Lin, C Zhao, X Huang - Cytokine & Growth Factor …, 2019 - Elsevier
Excessive activation of signal transducer and activator of transcription 3 (STAT3) signaling is
observed in a subset of many cancers, making activated STAT3 a highly promising potential …

Targeting STAT3 in cancer: how successful are we?

P Yue, J Turkson - Expert opinion on investigational drugs, 2009 - Taylor & Francis
Background: Aberrant activation of the signal transducer and activator of transcription
(STAT) 3 occurs in many human tumors. Moreover, studies utilizing genetic and …

[HTML][HTML] STAT3 signaling: anticancer strategies and challenges

PA Johnston, JR Grandis - Molecular interventions, 2011 - ncbi.nlm.nih.gov
Multiple lines of evidence place STAT3 at a central node in the development, progression,
and maintenance of many human tumors, and STAT3 has been validated as an anti-cancer …

[HTML][HTML] Overview of the STAT‑3 signaling pathway in cancer and the development of specific inhibitors

Y Gu, IS Mohammad, Z Liu - Oncology letters, 2020 - spandidos-publications.com
Signal transducer and activator of transcription (STAT) proteins represent novel therapeutic
targets for the treatment of cancer. In particular, STAT‑3 serves critical roles in several …

[HTML][HTML] Highlighted STAT3 as a potential drug target for cancer therapy

H Lee, AJ Jeong, SK Ye - BMB reports, 2019 - ncbi.nlm.nih.gov
Signal transducer and activator of transcription 3 (STAT3) is a cytoplasmic transcription
factor that regulates cell proliferation, differentiation, apoptosis, angiogenesis, inflammation …